{
    "nct_id": "NCT05972577",
    "official_title": "Optimization of Older Adult Allogeneic Hematopoietic Cell Transplant Candidates to Improve Survival (OTIS)",
    "inclusion_criteria": "* Age >= 60 years\n* Diagnosed with hematologic malignancy or bone marrow failure syndrome eligible for allogeneic hematopoietic cell transplantation. This includes acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndrome, myeloproliferative neoplasm, myelofibrosis, chronic myeloid leukemia, chronic lymphocytic leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, and aplastic anemia. Disease specific eligibility for allo-HCT to be determined by treating physician\n* Must be able to understand written and spoken English\n* Must be willing to attend all study visits and comply with study procedures for the entire length of the study\nHealthy volunteers allowed\nMust have minimum age of 60 Years",
    "exclusion_criteria": "* Documented history of dementia\n* No possibility of proceeding to allogeneic hematopoietic cell transplant within the next 6 months as determined by treating physician\n* Scheduled admission for allogeneic hematopoietic cell transplant within 30 days of enrollment\n* Inability or unwillingness to give written informed consent",
    "miscellaneous_criteria": ""
}